Vivos (RDGL) Operating Margin Growth (3y) (2014 - 2025)
Vivos (RDGL) Operating Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.01 Bn | 123.54 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.56 Bn | 74.02 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.82 Bn | 47.57 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 244.00 |
| 10 | Vivos | 23.99 Mn | 22.44 Mn | -3,105.00 | 643,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 643,108.00 |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | 300,188.00 |
| Mar 31, 2025 | 252,155.00 |
| Sep 30, 2024 | -1.56 Mn |
| Sep 30, 2023 | -798,847.00 |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 332,755.00 |
| Sep 30, 2019 | 884,834.00 |
| Mar 31, 2017 | -511,359.00 |
| Sep 30, 2016 | -1.60 Mn |
| Mar 31, 2016 | -1.08 Mn |
| Sep 30, 2015 | 105,607.00 |
| Mar 31, 2015 | -123,155.00 |
| Jun 30, 2014 | -488,375.00 |
| Mar 31, 2014 | -340,639.00 |